Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.

Not Applicable

Completed

• Conditions: Postpartum Anaemia
• Interventions: Drug: intravenous iron; Drug: oral iron

• Registration Number: NCT07110935
• Lead Sponsor: Federal Teaching Hospital Abakaliki

Brief Summary

Background:Anaemia is a condition of public health importance.Iron deficiency anaemia is the most common cause of anaemia in pregnancy.Postpartum anaemia poses a significant role for postpartum morbidity and mortality and should be treated.Postpartum iron deficiency anaemia warrants greater attention and higher quality of care.Oral iron treatment has been considered the standard of care.

However,parenteral iron treatment is expected to be advantageous in cases where oral iron therapy is not possible.As a result,there is increased interest in parenteral iron therapy.

Objectives:To determine the effect of treatment of postpartum anaemia with intravenous versus oral iron therapy at Federal Medical Centre,Umuahia.

Materials and Method:This study is a prospective randomized controlled study carried out in department of Obstetric and Gynaecology, Federal Medical Centre,Umuahia,the capital of Abia State,South-east, Nigeria. The study population comprised of postpartum women with mild to moderate anaemia within 48 hours of delivery who were randomized into two groups.One group will be given oral iron therapy and the other intravenous iron dextran.Response and comparative effects of treatment using either route of administration were assessed at 6 weeks postpartum.The biodata,obstetric characteristics and haemoglobin estimation of the respondents were recorded on a structured study proforma.The data obtained from the study was analyzed with the statistical package for the social sciences(SPSS) software.Continuous variables obtained from this study were expressed as mean and standard deviation while categorical variables were summarized using frequency and percentages.Association between categorical variables were done using chi square.P-value less than 0.05 was taken as significant.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-09-13
• Primary Completion: 2019-02-20
• Study Completion: 2019-02-20
• Study First Submitted: 2025-07-27
• Status Verified: 2025-08
• Study First Submitted QC: 2025-08-01
• Last Update Submitted: 2025-08-01
• Study First Posted: 2025-08-08
• Last Update Posted: 2025-08-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 290

Inclusion Criteria

• Women who have vaginal delivery of singleton baby and are seen within 48hours of childbirth
• Women with mild and moderate anaemia
• Women who gave their consent to participate in the study.

Exclusion Criteria

• Women with severe anaemia
• Women with multiple pregnancy
• Women with genotype HbSS
• Women with HIV infection
• Women who delivered by caesarean section
• Women with co-morbidity like hypertensive disorders, renal pathology
• Women who decline consent after adequate counseling.
• Previous and current history of adverse reaction to iron dextran

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
One hundred and forty five women who picked "i" were assigned intravenous iron therapy group	intravenous iron	-
One hundred and forty five women who picked "o" were assigned oral iron therapy group	oral iron	-

Primary Outcome Measures

Name	Time	Method
Mean postpartum haematocrit	Six weeks
Mean hematocrit following treatment with iron dextran	Six weeks

Secondary Outcome Measures

Name	Time	Method
Incidence and patterns of postpartum anaemia	Six weeks

Trial Locations

Locations (1)

Federal Medical Centre , Umuahia; 🇳🇬 Umuahia, Abia, Nigeria